These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of a Combined Value-Based Insurance Design and Medication Therapy Management Program on Diabetes Medication Adherence. Peaslee A, Wickizer M, Olson J, Topp R. J Manag Care Spec Pharm; 2016 Nov; 22(11):1303-1309. PubMed ID: 27783550 [Abstract] [Full Text] [Related]
3. Association of Medication Adherence with Hospital Utilization and Costs Among Elderly with Diabetes Enrolled in a State Pharmaceutical Assistance Program. Pednekar P, Heller DA, Peterson AM. J Manag Care Spec Pharm; 2020 Sep; 26(9):1099-1108. PubMed ID: 32857648 [Abstract] [Full Text] [Related]
4. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease. Spence MM, Makarem AF, Reyes SL, Rosa LL, Nguyen C, Oyekan EA, Kiyohara AT. J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326 [Abstract] [Full Text] [Related]
7. Effect of a Virtual Pharmacy Review Program: A Population Health Case Study. Muraywid B, Butkievich LE, Myers B. J Manag Care Spec Pharm; 2020 Jan; 26(1):24-29. PubMed ID: 31880223 [Abstract] [Full Text] [Related]
8. Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications. Clark B, DuChane J, Hou J, Rubinstein E, McMurray J, Duncan I. J Manag Care Pharm; 2014 Feb; 20(2):141-50. PubMed ID: 24456315 [Abstract] [Full Text] [Related]
10. The MEssaging for Diabetes Intervention Reduced Barriers to Medication Adherence Among Low-Income, Diverse Adults With Type 2. Mayberry LS, Mulvaney SA, Johnson KB, Osborn CY. J Diabetes Sci Technol; 2017 Jan; 11(1):92-99. PubMed ID: 27595710 [Abstract] [Full Text] [Related]
14. A Payer Perspective of the Costs of Urinary Tract and Skin and Soft Tissue Infections in Adults with Diabetes and the Relationship to Oral Antidiabetic Medication Nonadherence. Davis-Ajami ML, Pakyz A, Wu J, Baernholdt M. J Manag Care Spec Pharm; 2019 Dec; 25(12):1409-1419. PubMed ID: 31436479 [Abstract] [Full Text] [Related]
18. Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study. Buysman EK, Liu F, Hammer M, Langer J. Adv Ther; 2015 Apr; 32(4):341-55. PubMed ID: 25832470 [Abstract] [Full Text] [Related]
19. Association of Medication Adherence With HbA1c Control Among American Indian Adults With Type 2 Diabetes Using Tribal Health Services. Scarton L, Nelson T, Yao Y, DeVaughan-Circles A, Legaspi AB, Donahoo WT, Segal R, Goins RT, Manson SM, Wilkie DJ. Diabetes Care; 2023 Jun 01; 46(6):1245-1251. PubMed ID: 37068266 [Abstract] [Full Text] [Related]